Published 9 November 2026
Author(s): Dr Isabelle Widmer
Commercial teams get bigger budgets...
Tuesday, 17 Nov 2026
Note: “We” and “our” in the text below refer to Pfizer’s Publication Management Team
Barriers to knowledge transfer affect both patients and physicians: decisions might be made based on incomplete information which could result in poorer health outcomes. In recent times, the COVID-19 pandemic provided the clearest illustration of the need to have timely access to crucial medical findings (refs: Two Steps Forward, One Step Back — The Pandemic’s Impact on Open Access Progress and Open access in the age of a pandemic). Could open access publishing in biomedical research play a role in overcoming barriers by providing accessibility to published advances in research?
Studies and review articles (refs: Patients at the Heart of the Scientific Dialogue: An Industry Perspective and Defining patient centricity with patients for patients and caregivers: a collaborative endeavour) that emphasize the importance of patient-centricity in healthcare have underscored the importance of education and information, co-creation, access, and transparency in medical research. These studies found that patient-centricity is closely aligned with open access (OA) publishing, especially in industry-sponsored research. This alignment has the potential to foster public trust (see also UNESCO press release UNESCO sets ambitious international standards for open science). Paywalls may prove life-threatening for patients, when healthcare professionals (HCPs), physicians, and researchers—especially in countries where exchange rates make accessing peer-reviewed articles prohibitively expensive— lack access to the latest information; OA publishing can ensure that they can stay informed. OA is fundamental to medical research publishing because it removes the financial barriers faced by patients, HCPs, physicians, and other readers. This allows them to better inform their patients and plan for what is to come. Publishing OA also enhances transparency, committing to making research available to anyone—including reuse, in accordance with the Creative Commons license—encouraging trust in industry-sponsored research.
Tuesday, 17 Nov 2026
Tuesday, 17 Nov 2026
Tuesday, 17 Nov 2026
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Reading this content is completely free
Already have an account? Sign in